Ethnic variations in the pharmacological and nonpharmacological treatment of hypertension: Biopsychosocial perspective

Human Biology

Volumn 71, Issue 4, 1999, Pages 607-639

  Brownley, Kimberly A ^a   Hurwitz, Barry E ^a   Schneiderman, Neil ^a  

^a Department of Biology   (United States)

Author keywords

Ethnicity; Exercise; Herbal medicine; Hyperinsulinemia; Hypertension; Pharmacology

Indexed keywords

PIERINAE;

EID: 0033180279     PISSN: 00187143     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (211)

1. Aagaard, G.N. 1987. A nondrug approach to the treatment of hypertension. In Drug Therapy in Hypertension, J.I.M. Drayer, D.T. Lowenthal, and M.A. Weber, eds. New York: Marcel Dekker, 27-44.
2. Ajayi, A.A., and A.O. Akintomide. 1995. The efficacy and tolerability of amlodipine and hydrochlorothiazide in Nigerians with essential hypertension. J. Natl. Med. Assoc. 87(7):485-488.
3. Alpert, B.S., E.V. Dover, D.L. Booker et al. 1981. Blood pressure response to dynamic exercise in healthy children: Black vs. white. J. Pediatr. 99(4):556-560.
4. American Herbal Pharmacology Delegation. 1975. Herbal Pharmacology in the People's Republic of China. Washington, DC: National Academy of Sciences.
5. Anderson, N.B., and M. McNeilly. 1993. Autonomic reactivity and hypertension in blacks: Toward a contextual model. In Pathophysiology of Hypertension in Blacks, C.S. Fray and J.G. Douglas, eds. New York: Oxford University Press, 107-142.
6. Anderson, N.B., M. McNeilly, and H. Myers. 1992. Toward understanding race difference in autonomic reactivity: A proposed contextual model. In Individual Differences in Cardiovascular Response to Stress, J.R. Turner, A. Sherwood, and K.C. Light, eds. New York: Plenum Press, 125-140.
7. Arensman, F.W., F.A. Treiber, M.P. Gruber et al. 1989. Exercise-induced differences in cardiac output, blood pressure, and systemic vascular resistance in a healthy biracial population of 10-year-old boys. Am. J. Dis. Child. 143:212-216.
8. Aronoff, S.L., P.H. Bennett, P. Gordon et al. 1977. Unexplained hyperinsulinemia in normal and "pre-diabetic" Pima Indians compared with normal Caucasians: An example of racial differences in insulin secretion. Diabetes 26:827-840.
9. Aviv, A. 1996. Cellular calcium and sodium regulation, salt sensitivity, and essential hypertension in African Americans. Ethnic. Health 1(3):275-281.
10. Ayensu, E.S. 1991. Medicinal Plants of the West Indies. Algonac, MI: Reference Publications.
11. Baba, S., W.H. Pan, J. Ueshima et al. 1991. Blood pressure levels, related factors, and hyper" tension control status of Japanese and Americans. J Hum. Hypertens. 5(4):317-332.
12. Barker, DJ.P., P.D. Winter, C. Osmond et al. 1989. Weighl in infancy and death from ischémie heart disease. Lancet 2:577-580.
13. Baron, A.D., and G. Brechtel. 1993. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am. J. Physiol. 265(1 )(pt. 1):E61-E67.
14. Bengtsson, C., G. Blohme, L. Lapidus et al. 1984. Do antihypertensive drugs precipitate diabetes? Br. Med. J. 289(6457):1495-1497.
15. Benowitz, N.L. 1995. Antihypertensive agents. In Basic and Clinical Pharmacology, B. Katzung, ed. Norwalk, CT: Appleton and Lange, 147-170.
16. Berenson, O.S., W.A. Wattigney, and L.S. Webber. 1996. Epidemiology of hypertension from childhood to young adulthood in black, white, and Hispanic population samples. Public Health Rep. 11 (suppl. 2):3-6.
17. Berenson, G.S., A.W. Voors, L.S. Webber et al. 1979. Racial differences in parameters associated with blood pressure levels in children: The Bogalusa Heart Study. Metabolism 28(12):1218-1228.
18. Bianchini, F., and F. Corbetta. 1977. Health Plants of the World: Atlas of Medicinal Plants. New York: Newsweek Books.
19. Bjorntrop, P. 1987. Effects of physical training on blood pressure in hypertension. Eur. Heart J. 8(suppl. B):1-18.
20. Black, H.R., S. Ming, D.S. Poll et al. 1986. A comparison of the treatment of hypertension with Chinese herbal and Western medication. J. Clin. Hypertens. 2(4):371-378.
21. Blaustein, M.P., and C.E. Grim. 1991. The pathogenesis of hypertension: Black-white differences. Cardiovasc. Clin. 21(3):97-114.
22. Bonner, G. 1994. Hyperinsulinemia, insulin resistance, and hypertension. J. Cardiovasc. Pharmacol. 24(suppl. 2):S39-S49.
23. Bonnet, G. 1991. A multicenter study of doxazosin in the treatment of essential hypertension in France. Am. Heart J. 121(1)(pt. 2):335-340.
24. Breimer, D. 1994. Genetic polymorphisms in drug metabolism: Clinical implications and consequences in ADME studies. In The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines, S. Walker, C. Lumley, and N. McAuslane, eds. Dordrectht, the Netherlands: Kluwer, 13-26.
25. Brod, J. 1970. Mechanisms of hypertension. Circ. Res. 27(suppl. 1):163-166.
26. Brown, C.M., and R. Segal. 1996. Ethnic differences in temporal orientation and its implications for hypertension management. J. Health Soc. Behav. 37(4):350-361.
27. Brown, M.D., G.E. Moore, M.T. Korytkowski et al. 1997. Improvement of insulin sensitivity by short-term exercise training in hypertensive African American women. Hypertension 30(6): 1549-1553.
28. Brownley, K.A., K.C. Light, S.S. Girdler et al. 1997. Acute aerobic exercise reduces cardiovascular stress responses and alters sympathetic mediation in black and white men and women. Poster presented at the annual meeting of the Society of Behavioral Medicine, San Francisco, California.
29. Brownley, K.A., S.G. West, A.L. Hinderliter et al. 1996. Acute aerobic exercise reduces ambulatory blood pressure in borderline hypertensive men and women. Am. J. Hypertens. 9:200-206.
30. Bursztyn, M., D. Ben-Ishay, M. Shochina et al. 1993. Disparate effects of exercise training on glucose tolerance and insulin levels and on ambulatory blood pressure in hypertensive patients. J. Hypertens. 11(10):1121-1125.
31. Burt, V.L., P. Whelton, E.J. Roccella et al. 1995. Prevalence of hypertension in the US adult population: Results form the Third National Health and Nutrition Examination Survey. Hypertension 25(3):305-315.
32. Cannistra, L.B., CJ. O'Malley, and G.J. Balady. 1995. Comparison of outcome of cardiac rehabilitation in black women and white women. Am. J. Cardiol. 75:890-893.
33. Cappuccio, F.P., N.D. Markandu, D.R. Singer et al. 1993. Amlodipine and lisinopril in combination for the treatment of essential hypertension: Efficacy and predictors of response. J. Hypertens. 11(8):839-847.
34. Chalmers, J. 1993. First-line drugs: The position of the World Health Organization International Society of Hypertension. J. Hypertens. 11(suppl 5.):S381-S383.
35. Conway, J. 1970. Labile hypertension: The problem. Circ. Res. 27(suppl. 1):143-147.
36. Cooper, R.S., Y. Liao, and C. Rotimi. 1996. Is hypertension more severe among US blacks, or is severe hypertension more common? Ann. Epidemiol. 6:173-180.
37. Cooper, R., C. Rotimi, S. Ataman et al. 1997. The prevalence of hypertension in seven populations of West African origin. Am. J. Public Health 87(2):160-168.
38. Cruickshank, J.K., and D.G. Beevers. 1982. Epidemiology of hypertension: Blood pressure in blacks and whites. Clin. Sci. 62:1-6.
39. Cubeddu, L.X., J. Aranda, B. Singh et al. 1986. A comparison of verapamil and propranolol for the initial treatment of hypertension: Racial differences in response. J. Am. Med. Assoc. 256(16):2214-2221.
40. Cusi, D., C. Barlassina, T. Azzani et al. 1997. Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J. Appl. Physiol. 81 (1):318-325.
41. Dengel, D.R., R.E. Pratley, J.M. Hagbergetal. 1996. Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J. Appl. Phvsiol. 81(1):218-325.
42. Dimsdale, J.E., M.G. Ziegler, and R. Graham. 1988. The effect of hypertension, sodium, and race on isoproterenol sensitivity. Clin. Exp. Hypertens. (A) Theor. Practice 10(5):747-756.
43. Dimsdale, J.E., R.M. Graham, M.G. Ziegler et al. 1987. Age. race, diagnosis, and sodium effects on the pressor response to infused norepinephrine. Hypertension 10.564-569.
44. Dressler, W.W. 1993. Social and cultural dimensions of hypertension in blacks: Underlying mechanisms. In Pathophysiology of Hypertension in Blacks, J.C.S. Fray and J.G. Douglas, eds. New York: Oxford University Press, 69-89.
45. Dressler, W.W. 1994. Cross-cultural differences and social influences in social support and cardiovascular disease. In Social Support and Cardiovascular Disease, S.A. Shumaker and S.M. Czajkowski, eds. New York: Plenum Press, 179-182.
46. Eaton, C.B., D.C. Schaad, B. Rybicki et al. 1990. Risk factors for cardiovascular disease in US medical students: The preventive cardiology academic award collaborative data project. Am. J. Prev. Med. 6(suppl. 1): 14-22.
47. Edwards, D. 1995. Life events and hypertension: A negative finding. S. Afr. Med. J. 85(12):1346-1348.
48. Edwards, L.D. 1994. Acceptability of foreign data: Genetic, cultural, and environmental differences - do they matter? In The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines, S. Walker, C. Lumley, and N. McAuslane, eds. Dordrecht, the Netherlands: Kluwer, 161-177.
49. Eisner, G.M. 1990. Hypertension: Racial differences. Am. J. Kid. Dis. 16(4)(suppl. 1):35-40.
50. Ekelund, L.-G., C.M. Suchindran, J.M. Karon et al. 1990. Black-white differences in exercise blood pressure: The lipid research clinics program prevalence study. Circulation 31(5):1568-1574.
51. El-Sayed, M.S., B. Davies, and D.B. Morgan. 1990. Vasopressin and plasma volume response to submaximal and maximal exercise in man. J. Sports Med. Phys. Fitness 30:420-425.
52. Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group. 1993. Enalapril and analapril-hydrochlorothiazide in the treatment of essential hypertension. Clin. Ther. 15(2):364-373.
53. Fagard, R.H. 1995. Prescription and results of physical activity. J. Cardiovasc. Pharmacol. 25(suppl. 1):S20-S27.
54. Failde, I., B. Balkau, D. Costagliola et al. 1996. Arterial hypertension in the adult population of Guadeloupe and associated factors in subjects of African origin. Rev. Epidemiol. Sante Publique 44(5):417-426.
55. Farrell, S.W., H.W. Kohl, and T. Rogers. 1987. The independent effect of ethnicity on cardiovascular fitness. Hum. Biol. 59(4):657-666.
56. Fisher, N.D., C. Ferri, C. Bellini et al. 1997. Age, gender, and nonmodulation: A sexual dimorphism in essential hypertension. Hypertension 29(4):980-985.
57. Flack, J.M., E. Ensrud, S. Mascioli et al. 1991. Racial and ethnic modifiers of the salt-blood pressure response. Hypertension 7(1)(suppl. 1):115-121.
58. Forette, F., J. McClaran, M.P. Hervy et al. 1989. Nicardipine in elderly patients with hypertension: A review of experience in France. Am. Heart J. 117(1):256-261.
59. Fray, J.C.S. 1993a. Hypertension in blacks: Physiological, psychosocial, theoretical, and therapeutic challenges. In Pathophysiology of Hypertension in Blacks, J.C.S. Fray and J.G. Douglas, eds. New York: Oxford University Press, 3-22.
60. Fray, J.C.S. 1993b. Pathogenesis of hypertension in blacks: Features of an equilibrium model. In Pathophysiology of Hypertension in Blacks, J.C.S. Fray and J.G. Douglas, eds. New York: Oxford University Press, 239-270.
61. Freis, E.D. 1960. Hemodynamics of hypertension. Physiol. Rev. 40:27-54.
62. Freis, E.D. 1984. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic. Am. Heart J. 108(4)(pt. 2):1087-1091.
63. Freis, E.D., B.J. Materson, and W. Flamenbaum. 1983. Comparison of propranolol or hydrochlorothiazide alone for treatment of hypertension. III. Evaluation of the reninangiotensin system. Am. J. Med. 74:1029-1041.
64. Frishman, W.H., B.S. Bryzinski, L.R. Coulson et al. 1994. A multifactorial trial design to assess combination therapy in hypertension: Treatment with bisoprolol and hydrochlorothiazide. Arch. Intern. Med. 154:1461-1468.
65. Frishman, W.H., J.F. Burris, W.J. Mroczek et al. 1995. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II hypertension. J. Clin. Pharmacol. 35(2):182-188.
66. Frohlich, E.D. 1997. The sixth report of the Joint National Committee: An appropriate celebration of the 25th anniversary of the National High Blood Pressure Education Program. Hypertension 30:1305-1306.
67. Gellman, M.D., G.H. Ironson, J.B. Marks et al. 1997. The relationship between insulin resistance and sodium sensitivity using multiple blood pressure measurements. Ann. Behav. Med. 19:5067.
68. Gellman, M., S. Spitzer, G. Ironson et al. 1990. Posture, place, and mood effects on ambulatory blood pressure. Psychophysiology 27(5):544-551.
69. Griggs, B. 1981. Green Pharmacy: A History of Herbal Medicine. New York: Viking Press.
70. Grim, C.E., and T.W. Wilson. 1993. Salt, slavery, and survival: Physiological principles underlying the evolutionary hypothesis of salt-sensitive hypertension in Western Hemisphere blacks. In Pathophysiology of Hypertension in Blacks. J.C.S. Fray and J.G. Douglas, eds. New York: Oxford University Press, 25-49.
71. Gunther, K.H., P. Piorkowski, A. Serra Laguardia et al. 1987. Comparative studies in hypertension under different continental conditions. Nephron 47(suppl. 1):125-127.
72. Hagberg, J.M., S.J. Montain, W.H. Martin et al. 1989. Effect of exercise training on 60-to 69-year-old persons with essential hypertension. Am. J. Cardiol. 64:348-353.
73. Haines, A.P., A. Booroff, E. Goldenberg et al. 1987. Blood pressure, smoking, obesity, and alcohol consumption in black and white patients in general practice. J. Hum. Hypertens. 1(1):39-46.
74. Halberstein, R.A. 1983. The use of medicinal plants to control high blood pressure in the Caribbean. Fl. Anthropol. 36(3-4):167-172.
75. Halberstem, R.A., and G.M. Abrahmsohn. 1995. Vitamin C and dental healing. III. The nutrition factor. Gen. Dentistry 43(6):540-544.
76. Hall, W.D. 1985. Pharmacologic therapy of hypertension in blacks. In Hypertension in Blacks: Epidemiology, Pathophysiology, and Treatment, W.D. Hall, E. Saunders, and N.B. Shulman, eds. Chicago, IL: Year Book Medical Publishers, 182-208.
77. Hamet, P., and L. Gong. 1996. Chinese contribution to trials on antihypertensive therapy. J. Hypertens. 14(suppl. 2):S123-S127.
78. Harburg, E., E.E. Blakelock, and P.J. Roeper. 1979. Resentful and reflective coping with arbitrary authority and blood pressure: Detroit. Psychosom. Med. 41:189-202.
79. Harshfield, G.A., L.M. Dupaul, B.S. Alpert et al. 1990. Aerobic fitness and the diurnal rhythm of blood pressure in adolescents. Hypertension 15:810-814.
80. Havas, S., W. Fujimoto, N. Close et al. 1996. The NHLBI workshop on hypertension in Hispanic Americans, Native Americans, and Asian/Pacific Islander Americans. Public Health Rep. 111:451-458.
81. Hebert, L.A., G. Agarwal, S.E. Ladson-Wofford et al. 1996. Nocturnal blood pressure in treated hypertensive African Americans compared to treated hypertensive European Americans. J. Am. Soc. Nephrol. 7(10):2130-2134.
82. Hegsted, D.M. 1984. An overview of nutrition research. In NIH Workshop on Nutrition and Hypertension, M.J. Horan, M. Blaustein, J.B. Dunbar et al., eds. Bethesda, MD: National Institutes of Health. 9-16.
83. Henderson, G., and M. Primeaux. 1981. The importance of folk medicine. In Transcultural Health Care, G. Henderson and M. Primeaux, eds. Menlo Park, CA: Addison-Wesley. 59-77.
84. Hohn, A.R., D.A. Riopel, J.E. Keil et al. 1983. Childhood familial and racial differences in physiologic and biochemical factors related to hypertension. Hypertension 5(10):56-70.
85. Humphreys, G.S., and D.G. Delvin. 1968. Ineffectiveness of propranolol in hypertensive Jamaicans. Br. Med. J. 2:601-603.
86. Hypertension Detection and Follow-Up Program Cooperative Research Group. 1984. The effect of antihypertensive drug treatment on morality in the presence of resting electrocardiographic abnormalities at baseline: The HDFP experience. Circulation 70(6):996-1003.
87. Johnson, J.A., and B.S. Burlew. 1996. Metoprolol metabolism via cytochrome P450D26 in ethnic populations. Drug Metab. Dispos. 24(3):350-355.
88. Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure. 1998. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI). Arch. Intern. Med. 157:154-183.
89. Julius, S. 1993. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 21(6)(pt. 2):886-893.
90. Julius, S., T. Gudbrandsson, K. Jamerson et al. 1992. The hemodynamic link between insulin resistance and hypertension. J. Hypertens. 9:983-986.
91. Julius, S., T. Gudbrandsson, K. Jamerson et al. 1992. The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Press. 1(1):9-19.
92. Kalow, W., ed. 1992. Pharmacogenetics of Drug Metabolism. New York: Pergamon Press.
93. Kaplan, N.M. 1989. The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 149:1514-1520.
94. Kaplan, N.M. 1994. Treatment of hypertension: Rational and goals. In Clinical Hypertension, 6th ed., N.M. Kaplan, ed. Baltimore, MD: Williams and Wilkins. 145-170.
95. Kaplan, N.M. 1995. Guidelines for the treatment of hypertension: An American view. J. Hypertens. 13(suppl. 2):S113-S117.
96. Kaplan, N.M. 1996. The CARE Study: A postmarketing evaluation of ramipril in 11,100 patients. Clin. Ther. 18(4):658-67().
97. Katzung, B.G., and W.W. Parmley. 1995. Cardiac glycosides and other drugs used in congestive heart failure. In Basic and Clinical Pharmacology, B. Katzung, ed. Norwalk, CT: Appleton and Lange. 188-204.
98. Kenney, M.J., and D.R. Seals. 1993. Postexercise hypotension: Key features, mechanisms, and clinical significance. Hypertension 22:653-664.
99. Klag, M.J., P.K. Whelton, B.L. Randall et al. 1997. End-stage renal disease in African American and white men: 16-year MRFIT findings. J. Am. Med. Assoc. 277(16):1293-1298.
100. Kojima, S., Y. Kawano, Y. Yoshitomi et al. 1995. Comparison of first-line antihypertensive drugs by a randomized crossover method: A preliminary report. Hypertens. Res. 18(4):303-305.
101. Krakoff, L.R., E.L. Bravo, M.L. Tuck et al. 1990. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Am. J. Hypertens. 3(12)(pt. 2):318S-325S.
102. Kreig, M.B. 1964. Green Medicine: The Search for Plants That Heal. Chicago, IL: Rand McNally.
103. Lander, E.S., and N.J. Schork. 1994. Genetic dissection of complex traits. Science 265:2037-2048.
104. Landsberg, L. 1996. Insulin sensitivity in the pathogenesis of hypertension and hypertensive complications. Clin. Exp. Hypertens. 18(3-4):337-346.
105. Langford, H.G., R.L. Watson, and B.H. Douglas. 1968. Factors affecting blood pressure in population groups. Traits. Assoc. Am. Physicians 81:135-146.
106. Lassey, M.L., W.R. Lassey, and M.J. Jinks. 1997. Health Care Systems Around the World: Characteristics, Issues, Reforms. Upper Saddle River, NJ: Prentice Hall.
107. Lau, Y.T., E. Wu, H.C. Liang et al. 1992. Erythrocyte sodium-lithium contertransport in Chinese: Its relationship to family history of hypertension. Clin. Exp. Hypertens. 14(3):489-503.
108. Lehrer, S., J. Rabin, T. Kalir et al. 1993. Estrogen receptor variant and hypertension in women. Hypertension 21(4):439-441.
109. Levy, S.B., L.B. Talner, M.N. Coel et al. 1978. Renal vasculature in essential hypertension: Racial differences. Ann. Intern. Med. 88:12-16.
110. Light, K.C., and J.R. Turner. 1992. Stress-induced changes in the rate of sodium excretion in healthy black and white men. J. Psychsom. Res. 36(5):497-508.
111. Light, K.C., J.R. Turner, A.L. Hinderliter et al. 1993. Race and gender comparisons. II. Predictions of work blood pressure from laboratory baseline and cardiovascular reactivity measures. Health Psychol. 12:366-375.
112. Light, K.C., J.R. Turner, A.L. Hinderliter et al. 1994. Comparison of cardiac versus vascular reactors and ethnic groups in plasma epinephrine and norepinephrine responses to stress. Int. J. Behav. Med. 1(3):229-246.
113. Lipsitz, L.A., C.M. Connelly, M. Kelley-Gagnon et al. 1995. Effects of chronic estrogen replacement therapy on beat-to-beat blood pressure dynamics in healthy postmenopausal women. Hypertension 26:711-715.
114. Liu, K., and S. Levinson. 1996. Comparisons of blood pressure between Asian American children and children from other racial groups in Chicago. Public Health Rep. 111(suppl. 2):65-67.
115. Livingston, I.L., D.M. Levine, and R.D. Moore. 1991. Social integration and black intraracial variation in blood pressure. Ethnic. Dis. 1:135-149.
116. Mallion, J.M., and A.I. Goldberg. 1996. Global efficacy and tolerability of lowartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension. Blood Press. Suppl. 2:82-86.
117. Manolio, T.A., G.L. Burke, P.J. Savage et al. 1994. Exercise blood pressure response and 5-year risk of elevated blood pressure in a cohort of young adults: The CARDIA study. Am. J. Hypertens. 7(3):234-241.
118. Manolis, A.J., I. Gavras, M. Pieprzak et al. 1995. Isradipine versus captopril in patients with essential hypertension. Clin. Ther. 17(4):648-655.
119. Manuck, S.B., A.L. Kasprowicz, and M.F. Muldoon. 1990. Behaviorally evoked cardiovascular reactivity and hypertension: Conceptual issues and potential associations. Ann. Behav. Med. 12:17-29.
120. Marceau, M., N. Kouame, Y. Lacourciere et al. 1993. Effects of different training intensities on 24-hour blood pressure in hypertensive subjects. Circulation 88(6):2803-2811.
121. Mark, A.L., and E.A. Anderson. 1995. Genetic factors determine the blood pressure response to insulin resistance and hyperinsulinemia: A call to refocus the insulin hypothesis of hypertension. Proc. Soc. Exp. Biol. Med. 208:330-336.
122. Markovitz, J.H., C.E. Lewis, P.W. Sanders et al. 1997. Relationship of diastolic blood pressure with cyclic GMP excretion among young adults (the CARDIA study): Influence of a family history of hypertension - coronary artery risk development in young adults. J. Hypertens. 15(9):955-962.
123. Martin, J.E., P.M. Dubbert, and W.C. Cushman. 1990. Controlled trial of aerobic exercise in hypertension. Circulation 81:1560-1567.
124. Materson, B.J., D.J. Reda, and W.C. Cushman. 1995. Department of Veterans Affairs single-drug therapy of hypertension study: Revised figures and new data - Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Am. J. Hypertens. 8(2):189-192.
125. Materson, B.J., D.J. Reda, W.C. Cushman et al. 1993. Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo. New Engl. J. Med. 328(13):914-921.
126. Mercuro, G., S. Zoncu, I. Pilia et al. 1997. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Am. J. Cardiol. 80(5):652-655.
127. Meredith, I.T., P. Friberg, G.L. Jennings et al. 1990. Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 18(5):575-582.
128. Mills, D.E., and R.P. Ward. 1986. Attenuation of stress-induced hypertension by exercise independent of training effects: An animal model. J. Behav. Med. 9(6):599-605.
129. Mills, P.J., J.E. Dimsdale, M.G. Ziegler et al. 1995. Racial differences in epinephrine and beta-2-adrenergic receptors. Hypertension 25(1):88-91.
130. Miura, Y., M. Watanabe, and K. Yoshinaga. 1991. An evaluation of the efficacy and safety of doxazosin in hypertension associated with renal dysfunction: The Japanese Doxazosin Study Group. Am. Heart J. 121(1)(pt. 2):381-388.
131. MMWR Morbidity and Mortality Weekly Report. 1995. Self-treatment with herbal and other plant-derived remedies: Rural Mississippi, 1993 [online]. Abstract from MEDLINE File: FirstSearch Item: 95191486
132. Moerman, D.E. 1977. American Medical Ethnobotany: A Reference Dictionary. New York: Garland.
133. Morton, J.F. 1981. Atlas of Medicinal Plants of Middle America: Bahamas to Yucatan. Springfield, IL: Charles C Thomas.
134. Moser, M. 1993. A critique of the Fifth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. J. Hypertens. 11(suppl. 5):S384-S388.
135. Moser, M. 1995. Black-white difference in response to antihypertensive medication. J. Natl. Med. Assoc. 87(suppl. 8):612-613.
136. Moser, M., and J. Lunn. 1981. Comparative effects of pindolol and hydrochlorothiazide in black hypertensive patients. Angiology 32:561-566.
137. Moser, M., and J. Lunn. 1982. Responses to captopril and hydrochlorothiazide in black patients with hypertension. Clin. Pharmacol. Ther. 32:307-312.
138. Naito, C. 1994. Ethnic effects on pharmacokinetic parameters. In The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines, S. Walker, C. Lumley, and N. McAuslane, eds. Dordrecht, the Netherlands: Kluwer Academic, 161-177.
139. Neel, J.V. 1962. Diabetes mellitus: A thrifty genotype rendered detrimental by "progress"? Am. J. Hum. Genet. 14:353-362.
140. Nelesen, R.A., J.E. Dimsdale, P.J. Mills et al. 1995. Relationship of insulin, race, and hypertension with hemodynamic reactivity to a behavioral challenge. Am. J. Hypertens. 8(1):12-19.
141. O'Dea, K. 1991. Westernization and non-insulin-dependent diabetes in Australian Aborigines. Ethnic. Dis. 1(2):171-187.
142. Oliver-Bever, B. 1986. Medicinal Plants in Tropical West Africa. Cambridge, England: Cambridge University Press.
143. Ooi, W.L., N.S. Budner, H. Cohen et al. 1989. Impact of race on treatment response and cardiovascular disease among hypertensives. Hypertension 14(3):227-234.
144. Parker, J.C. 1980. Hypertension and the red cell. New Engl. J. Med. 302:804-805.
145. Pavlik, V.N., D.J. Hyman, and C. Vallbona. 1996. Hypertension control in multi-ethnic primary care clinics. J. Hum. Hypertens. 10(suppl. 3):S19-S23.
146. Payan, D.G., and B.G. Katzung. 1995. Nonsteroidal anti-inflammatory drugs; nonopioid analgesics; drugs used in gout. In Basic and Clinical Pharmacology. B. Katzung, ed. Norwalk, CT: Appleton and Lange, 536-559.
147. Payer, L. 1988. Medicine and Culture: Varieties of Treatment in the United States, England, West Germany, and France. New York: Henry Holt.
148. Perez-Stable, I.J. 1994. Cardiovascular disease. In Latino Health in the US: A Growing Challenge, C.W. Molina and M. Aguirre-Molina, eds. Washington, DC: American Public Health Association, 247-277.
149. Pivarnik, J.M., M.S. Bray, A.C. Hergenroeder et al. 1995. Ethnicity affects aerobic fitness in US adolescent girls. Med. Sci. Sports Exerc. 27(12):1635-1638.
150. Primm, B.J. 1977. Poverty, folk remedies, and drug misuse among the black elderly. In Health and the Black Aged: Proceedings of a Research Symposium, W.H. Watson, ed. Washington, DC: National Center on Black Aged, 63-65.
151. Prisant, L.M., and G.A. Mensah. 1996. Use of beta-adrenergic receptor blockers in blacks. J. Clin. Pharmacol. 36(10):867-873.
152. Quisumbing, E. 1951. Medicinal Plants of the Philippines. Republic of the Philippines Department of Agriculture and Natural Resources Technical Bulletin 16. Manila, Philippines: Bureau of Printing.
153. Radaelli, A., M. Piepoli, S. Adamopoulous et al. 1992. Effects of mild physical activity, atenolol, and the combination on ambulatory blood pressure in hypertensive subjects. J. Hypertens. 10(10):1279-1282.
154. Reaven, G.M. 1988. Role of insulin resistance in human disease: Banting lecture. Diabetes 37:1595-1607.
155. Reed, M.J., H. Ho, R. Donnelly et al. 1994. Salt-sensitive and carbohydrate-sensitive rodent hypertension: Evidence of strain differences. Blood Press. 3:197-201.
156. Regensteiner, J.G., W.R. Hiatt, R.L. Byyny et al. 1991. Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women. J. Clin. Pharmacol. 31:543-548.
157. Resnick, L.M., J.H. Laragh, J.E. Sealey et al. 1983. Divalent cations in essential hypertension: Relations between serum ionized calcium, mangesium, and plasma renin activity. New Engl. J. Med. 309:888-891.
158. Rimoin, D.L., and J.H. Saiki. 1968. Diabetes mellitus among the Navajo. II. Plasma glucose and insulin responses. Arch. Intern. Med. 122:6-9.
159. Rotimi, C., A. Puras, R. Cooper et al. 1996. Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension 27(3)(p. 2):558-563.
160. Rowlands, D., J. De Givanni, R. McLeay et al. 1982. Cardiovascular response in black and white hypertensives. Hypertension 4:817-820.
161. Ryan, A.S., R.E. Pratley, A.P. Goldberg et al. 1996. Resistive training increases insulin action in postmenopausal women. J. Gerontol, ser. A, Biol. Sci. Med. Sci. 51(5):M199-M205.
162. Saab, P.G., M.M. Llabre, B.E. Hurwitz et al. 1992. Myocardial and peripheral vascular responses to behavioral challenges and their stability in black and white Americans. Psychophysiology 29(4):384-397.
163. Saab, P.G., N. Tischenkel, S.B. Spitzer et al. 1991. Race and blood pressure status influences cardiovascular responses to challenge. J. Hypertens. 9:249-258.
164. Saad, M.F., S. Lillioja, B.L. Nyomba et al. 1991. Racial differences in the relation between blood pressure and insulin resistance. New Engl. J. Med. 324(11):733-739.
165. Suku, K., K. Hirata, B. Zhang et al. 1992. Effects of Chinese herbal drugs on serum lipids, lipoproteins, and apolipoproteins in mild to moderate essential hypertensive patients. J. Hum. Hypertens. 6(5):393-395.
166. Salmon, S.E., and A.C. Sartorelli. 1995. Cancer chemotherapy. In Basic and Clinical Pharmacology, B. Katzung, ed. Norwalk, CT: Appleton and Lange, 823-856.
167. Schneiderman, N., and J.S. Skyler. 1996. Insulin metabolism, sympathetic nervous system regulation, and coronary heart disease prevention. In Behavioral Medicine Approaches to Cardiovascular Disease Prevention, K. Orth-Gomer and N. Schneiderman, eds. Mahwah, NJ: Lawrence Erlbaum Associates, 105-133.
168. Scotch, N.A. 1963. Sociocultural factors in the epidemiology of Zulu hypertension. Am. J. Public Health 53:1205-1213.
169. Seaforth, C.E., C.D. Adams, and Y. Sylvester. 1985. A Guide to the Medicinal Plants of Trinidad and Tobago. London, England: Commonwealth Secretariat Marlborough House.
170. Seals, D.R., and M.J. Reiling. 1991. Effect of regular exercise on 24-hour arterial pressure in hypertensive humans. Hypertension 18(5):583-592.
171. Seedat, Y.K. 1980. Trial of atenolol and chlorthialidone for hypertension in black South Africans. Br. Med. J. 281:1241-1243.
172. Sherwin, R., A. Sengupta, and S. Havas. 1996. Blood pressure in minorities screened for the Multiple Risk Factor Intervention Trial. Public Health Rep. 111(suppl. 2):68-70.
173. Sherwood, A., and A.L. Hinderliter. 1993. Responsiveness to alpha-and beta-adrenergic receptor agonists: Effects of race in borderline hypertensive compared to normotensive men. Am. J. Hypertens. 6(7):630-635.
174. Sherwood. A., K.C. Light, and J.A. Blumenthal. 1989. Effects of aerobic exercise training on hemodynamic responses during psychosocial stress in normotensive and borderline hypertensive type A men: A preliminary report. Psychosom. Med. 51:123-136.
175. Sherwood, A., C.W. May, W.C. Siegel et al. 1995. Ethnic differences in hemodynamic responses to stress in hypertensive men and women. Am. J. Hypertens. 8(6):552-557.
176. Skoularigis, J., V. Strugo, C. Zambakides et al. 1996. Comparison of captopril-thiazide and enalapril-thiazide combinations in the management of mild to moderate black hypertensive patients: How important is diuretic dose and duration of action of the ACE-inhibitor? Int. J. Clin. Pharmacol. Ther. 34(6):263-268.
177. Steyn, K., J. Fourie, C. Lombard et al. 1996. Hypertension in the black community of the Cape Peninsula, South Africa. East Afr. Med. J. 11:758-763.
178. Sussman, L.K. 1988. The use of herbal and biomedical pharmaceuticals on Mauritius. In The Context of Medicines in Developing Countries, S. Van Der Geest and S.R. Whyte, eds. Dordrecht, the Netherlands: Kluwer Academic, 199-207.
179. Svetkey, L.P., S.P. McKeown, and A.F. Wilson. 1996. Heritability of salt sensitivity in black Americans. Hypertension 28(5):854-858.
180. Swales, J.D., ed. 1995. Manual of Hypertension. Oxford, England: Blackwell Scientific.
181. Tamir, A., and S. Cachola. 1994. Hypertension and other cardiovascular risk factors. In Confronting Critical Health Issues of Asian and Pacific Islander Americans, N.S. Zane, D.T. Takeuchi. and K.N.J. Youn, eds. London, England: SAGE Publications, 209-231.
182. Tischenkel, N.J., P.G. Saab, N. Schneiderman et al. 1989. Cardiovascular and neurohumoral responses to behavioral challenge as a function of race and sex. Health Psychol. 8(5):503-524.
183. Tobian, L.J. 1977. Experimental models for the study of hypertension. In Hypertension: Mechanisms, Diagnosis, and Management, J.O. Davis, J.H. Laragh, and A. Selwyn, eds. New York: HP Publishing, 15-24.
184. Tomiyama, H., T. Kushiro, H. Abeta et al. 1992. Blood pressure response to hyperinsulinemia in salt-sensitive and salt-resistant rats. Hypertension 20:596-600.
185. Townsend, R., B. Haggert, C. Liss et al. 1995. Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension. Clin. Ther. 17(5):911-923.
186. Treiber, F.A., H. Davis, L. Musante et al. 1993. Ethnicity, gender, family history of myocardial infarction, and hemodynamic responses to laboratory stressor in children. Health Psychol. 12(1):6-15.
187. Treiber, F.A., L. Musante, W.B. Strong et al. 1989. Racial differences in young children's blood pressure: Response to dynamic exercise. Am. J. Dis. Child. 143:720-723.
188. Trials of Hypertension Prevention Collaborative Research Group. 1992. The effects of non-pharmacological interventions on blood pressure of persons with high normal levels. J. Am. Med. Assoc. 267:1213-1220.
189. Tuck, M.L. 1992. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension 19:167-177.
190. Tyroler, H.A., I.S. Glasunov, A.D. Deev et al. 1978. A Comparison of High Blood Pressure Prevalence and Treatment Status in Selected US and USSR Populations. NIH Publication 79-1272. Washington, DC: US Department of Health and Human Services, 423-433.
191. Urata, H., Y. Tanabe, A. Kiyonaga et al. 1987. Antihypertensive and volume-depleting effects of mild exercise on essential hypertension.
192. Veterans Administration Cooperative Study Group on Antihypertensive Agents. 1982. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Comparison of propranolol and hydrochlorthiazide for the initial treatment of hypertension. I. Results of short time titration with emphasis on racial differences in response. J. Am. Med. Assoc. 248:1966-2003.
193. Veterans Administration Cooperative Study Group on Antihypertensive Agents. 1983. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension. Am. J. Cardiol. 52:1230-1237.
194. Wade, J.R., and N.C. Sambol. 1995. Felodipine population dose-response and concentration-response relationships in patients with essential hypertension. Clin. Pharmacol. Ther. 57(5):569-581.
195. Weinberger, M.H., J.Z. Miller, F.C. Luft et al. 1986. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8(suppl. 2):127-134.
196. Weir, M.R., J.M. Gray, R. Paster et al. 1995. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. Hypertension 26(1):124-130.
197. West, S.G., C. Stanwyck, K. Brownley et al. 1997. Salt restriction increases norepinephrine and cholesterol in blacks more than in whites. Ann. Behav. Med. 19:5067.
198. White, A. 1985. Herbs of Ecuador: Medicinal Plants. Quito, Ecuador: Ediciones Libri Mundi.
199. Wilkerson, J., B. Gutin, and S.M. Horvath. 1977. Exercise-induced changes in blood, red cell, and plasma volumes in man. Med. Sci. Sports 9:155-158.
200. Wong, N.D., S. Ming, H. Y. Zhou et al. 1991. A comparison of Chinese traditional and Western medical approaches for the treatment of mild hypertension. Yale J. Biol. Med. 64(1):79-87.
201. World Health Organization. 1993. Working Group on the Safety and Efficacy of Herbal Medicine. Report series RS/92/GE/15(PHL). Manila, Philippines: World Health Organization.
202. World Health Organization Guidelines Sub-Committee. 1993. 1993 Guidelines for the management of mild hypertension: Memorandum from a World Health Organization/International Society of Hypertension meeting. J. Hypertens. 11:905-918.
203. Wright, J.T. 1988. Profile of systemic hypertension in black patients. Am. J. Cardiol. 61:41H-45H.
204. Wright, J.T., and J.G. Douglas. 1993. Drug therapy in black hypertensives. In Pathophysiology of Hypertension in Blacks, C.S. Fray and J.G. Douglas, eds. New York: Oxford University Press, 271-291.
205. Wu, X., X. Duan, D. Gu et al. 1995. Prevalence of hypertension and its trends in Chinese populations. Int. J. Cardiol. 52(1):39-44.
206. Yapp, C.K., L.S. Taylor, C.Y. Ow et al. 1995. Hypertension management: A comparison of urban versus rural general practitioners in western Australia. Clin. Exp. Pharmacol. Physiol. 22:447-449.
207. Zanchetti, A. 1993. World Health Organization-International Society of Hypertension versus United States guidelines on hypertension treatment: Similarities and differences. J. Hypertens. 11(suppl. 5):S380.
208. Zanchetti, A. 1995. Guidelines for the management of hypertension: The World Health Organization/International Society of Hypertension view. J. Hypertens. 13(suppl. 2):S119-S122.
209. Zhou, H.-H., R.P. Koshakji, D.J. Silberstein et al. 1989. Racial differences in drug response: Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. New Engl. J. Med. 320:565-570.
210. Zimmet, P.Z. 1993. Hyperinsulinemia: How innocent a bystander? Diabetes Care 16(suppl. 3):56-70.
211. Zimmet, P., S. Whitehouse, and J. Kiss. 1979. Ethnic variability in the plasma insulin response to oral glucose in Polynesian and Micronesian subjects. Diabetes 28:624-628.